Cullinan Therapeutics, Inc. (CGEM) vs MeiraGTx Holdings PLC (MGTX)
- Cullinan Therapeutics, Inc. CGEM 12.93 −7.64%
- MeiraGTx Holdings PLC MGTX 9.28 −6.17%
Cullinan Therapeutics, Inc. and MeiraGTx Holdings PLC are both Biotechnology companies. Cullinan Therapeutics, Inc. and MeiraGTx Holdings PLC are of similar size ($949.9M and $901.0M). Cullinan Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; MeiraGTx Holdings PLC trades at 12.2×. MeiraGTx Holdings PLC has the higher net margin (19.9% vs 0.00%) and the higher return on invested capital (66.6% vs 0.00%). Across the 13 metrics below, MeiraGTx Holdings PLC leads on 10 and Cullinan Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | CGEM | MGTX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 97.95% | 65.16% |
| Operating margin | 0.00% | 46.30% | 0.00% |
| Net margin | 0.00% | 19.87% | 0.00% |
| Free cash flow margin | 0.00% | 2.55% | 0.00% |
| Return on equity | (50.30%) | 72.22% | (56.36%) |
| Return on assets | (46.30%) | 26.54% | (48.04%) |
| Return on invested capital | 0.00% | 66.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack